Evaluation of novel nutraceuticals based on the combination of oat beta-glucans and a green coffee phenolic extract to combat obesity and its comorbidities. A randomized, dose–response, parallel trial-Reference-Cited by-同舟云学术

Evaluation of novel nutraceuticals based on the combination of oat beta-glucans and a green coffee phenolic extract to combat obesity and its comorbidities. A randomized, dose–response, parallel trial

Published:2022 Issue:2 Volume:13 Page:574-586
ISSN:2042-6496
Container-title:Food & Function
language:en
Short-container-title:Food Funct.

Author:

Mateos Raquel¹^ORCID,García-Cordero Joaquín¹,Bravo-Clemente Laura¹^ORCID,Sarriá Beatriz¹^ORCID

Affiliation:

1. Department of Metabolism and Nutrition, Institute of Food Science, Technology and Nutrition (ICTAN-CSIC), Spanish National Research Council (CSIC), José Antonio Nováis 10, 28040 Madrid, Spain

Abstract

Consumption of a nutraceutical combining oat beta-glucans and a decaffeinated green coffee extract rich in phenolic compounds shows beneficial effects in obese/overweight adults.

Funder

Ministerio de Economía y Competitividad

Comunidad de Madrid

Publisher

Royal Society of Chemistry (RSC)

Subject

General Medicine,Food Science

Link

http://pubs.rsc.org/en/content/articlepdf/2022/FO/D1FO02272E

Reference61 articles.

1. Obesity and overweight, 2019, Retrieved from https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

2. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation